Loading...
XOSLTRMED
Market cap27mUSD
Dec 23, Last price  
2.66NOK
1D
1.92%
1Q
158.25%
Jan 2017
-97.25%
IPO
-91.13%
Name

Nordic Nanovector ASA

Chart & Performance

D1W1MN
XOSL:TRMED chart
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
-11.99%
Revenues
0k
Net income
-27m
L-91.47%
-417,075,000-441,303,000-311,241,000-26,561,000
CFO
-64m
L-84.33%
0-398,206,000-403,458,000-409,079,000-64,090,000
Earnings
Apr 11, 2025

Profile

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. The company was founded in 2017 and is headquartered in Oslo, Norway.
URL
https://www.nordicnanovector.com/
IPO date
Jul 07, 2014
Employees
Domiciled in
NO
Incorporated in
NO

Valuation

Title
NOK in thousands, except ratios and share amounts
FYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
4,080
28,773
342,871
Unusual Expense (Income)
NOPBT
(4,080)
(28,773)
(342,871)
NOPBT Margin
Operating Taxes
1,000
311,241
1,165
Tax Rate
NOPAT
(4,081)
(340,014)
(344,036)
Net income
(26,561)
-91.47%
(311,241)
-29.47%
(441,303)
5.81%
Dividends
Dividend yield
Proceeds from repurchase of equity
147
250,808
423,568
BB yield
-0.07%
-186.19%
-19.64%
Debt
Debt current
159
5,508
Long-term debt
159
5,508
Deferred revenue
Other long-term liabilities
Net debt
(41,767)
(96,234)
(265,693)
Cash flow
Cash from operating activities
(64,090)
(409,079)
(403,458)
CAPEX
(5,628)
(259)
Cash from investing activities
6,276
(2,464)
863
Cash from financing activities
(332)
228,125
385,096
FCF
(4,551)
(334,609)
(344,295)
Balance
Cash
41,767
96,552
276,709
Long term investments
Excess cash
41,767
96,552
276,709
Stockholders' equity
25,856
(2,708)
(39,214)
Invested Capital
246,069
67,470
188,631
ROIC
ROCE
EV
Common stock shares outstanding
174,787
115,130
94,819
Price
1.29
10.26%
1.17
-94.85%
22.74
44.75%
Market cap
225,475
67.39%
134,702
-93.75%
2,156,179
94.72%
EV
183,708
38,468
1,890,486
EBITDA
(3,363)
(17,571)
(331,500)
EV/EBITDA
Interest
414
Interest/NOPBT